Biogen Inc (BIIB)

218.03
-1.61(-0.73%)
  • Volume:
    154,276
  • Day's Range:
    216.61 - 219.45
  • 52 wk Range:
    187.16 - 351.86

BIIB Overview

Prev. Close
219.64
Day's Range
216.61-219.45
Revenue
10.82B
Open
218.81
52 wk Range
187.16-351.86
EPS
14.01
Volume
154,276
Market Cap
31.5B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
989,923
P/E Ratio
15.10
Beta
0.387
1-Year Change
-36.06%
Shares Outstanding
145,113,047
Next Earnings Date
24 Oct 2022
What is your sentiment on Biogen?
or
Vote to see community's results!

Biogen Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Biogen Inc Analysis

Biogen Inc Company Profile

Biogen Inc Company Profile

Employees
9100

Biogen Inc. is a global biopharmaceutical company. It is focused on discovering, developing and delivering therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; ADUHELM for the treatment of Alzheimer's disease; and FUMADERM for the treatment of severe plaque psoriasis. It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions; RITUXAN HYCELA for the treatment of non-Hodgkin's lymphoma and CLL; GAZYVA; OCREVUS; and other potential anti-CD20 therapies, including mosunetuzumab.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellNeutralSell
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellStrong SellBuyStrong Sell
  • Hit the jackpot with this one kaching
    0
    • Biib is going to give eps $30.21/share,is good buy for long term.
      0
      • Strong buy, biib upgrade target price to $385..stock will up again on next Monday.
        3
        • Eps 30.21/share, is a good buy..
          0
          • Biib is very good stock, can invest for long term. Share will up soon, eps will given on Feb 03,means you need to hold the stock on around Feb 1st
            0
            • bull...call
              0
              • Why has the stock gone down???
                0
                • where do u see biib on the short run ??!!
                  0